Patent · US Active

Oridonin analogs, compositions, and methods related thereto

US9725460B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 5, 2015
Grant dateAug 8, 2017
Priority date
Expiry dateOct 5, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D515/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Certain embodiments are directed to oridonin analogs or derivatives. In certain aspects, the derivatives are used as anticancer or anti-inflammatory agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.